| 1 |
Drug-induced immune hemolytic anemia: the last 30 years of changes |
|
|
| P.A. Arndt |
|
| Immunohematology. 2019; 30(2): 44 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Les anémies hémolytiques immunologiques médicamenteuses : étude rétrospective de 10 observations |
|
|
| A. Bollotte,T. Vial,P. Bricca,C. Bernard,C. Broussolle,P. Sève |
|
| La Revue de Médecine Interne. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Protein coronas suppress the hemolytic activity of hydrophilic and hydrophobic nanoparticles |
|
|
| Krishnendu Saha,Daniel F. Moyano,Vincent M. Rotello |
|
| Materials Horizons. 2014; 1(1): 102 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma |
|
|
| Marisol Betensky,Char Witmer,Michael J. Fisher,Sandra Nance,Mitchell J. Weiss,Deborah A. Sesok-Pizzini |
|
| Transfusion. 2014; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Drug-induced immune hemolytic anemia (Direct Antiglobulin Test positive) |
|
|
| R.S. Sarkar,J. Philip,R.S. Mallhi,Neelesh Jain |
|
| Medical Journal Armed Forces India. 2013; 69(2): 190 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study |
|
|
| Shaojun Shi, Yani Liu, Zhongfang Li, Heng Zheng, Yongning Lv, Hui Chen |
|
| Clinical Therapeutics. 2010; 32(10): 1832 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
